Table 1.
E2 human monoclonal antibody panel
| Antibody | Antigenic domain | Neutralizing | Bind denatured E2 | Source |
| CBH-4D | A | N | N | (26) |
| CBH-4G | A | N | N | (26) |
| CBH-4B | A | N | N | (26) |
| CBH-20 | A | N | N | (56) |
| CBH-21 | A | N | N | (56) |
| CBH-22 | A | N | N | (56) |
| HC-1 | B | Y | N | (27) |
| HC-11 | B | Y | N | (27) |
| A27* | B | Y | N | — |
| CBH-7 | C | Y | N | (26) |
| CBH-23* | C | Y | N | — |
| HC84.20 | D | Y | N | (25) |
| HC84.24 | D | Y | N | (25) |
| HC84.26 | D | Y | N | (25) |
| HC33.1 | E | Y | Y | (12) |
| HC33.4 | E | Y | Y | (12) |
*
A27 and CBH-23 hmAbs not previously described; neutralization and denatured E2 binding measured in the same manner as other hmAbs in the panel (25).